These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25465842)

  • 1. Pitfalls of bioresorbable vascular scaffold thrombosis--be sure to cover it all.
    Abu Sharar H; Katus HA; Bekeredjian R
    Int J Cardiol; 2014 Dec; 177(3):1067-8. PubMed ID: 25465842
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute stent thrombosis of a bioresorbable vascular scaffold implanted for ST-segment elevation myocardial infarction.
    Miyazaki T; Panoulas VF; Sato K; Naganuma T; Latib A; Colombo A
    Int J Cardiol; 2014 Jun; 174(2):e72-4. PubMed ID: 24784914
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary artery perforation and acute scaffold thrombosis after bioresorbable vascular scaffold implantation for a calcified lesion.
    Lee WC; Fang HY; Wu CJ
    Int J Cardiol; 2016 Nov; 222():620-621. PubMed ID: 27517650
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of post-dilatation on strut apposition of second-generation bioresorbable vascular scaffolds: Key role for scaffold thrombosis and prognosis?
    Frangieh AH; Jaguszewski M; Imori Y; Obeid S; Templin C
    Cardiol J; 2018; 25(1):148-150. PubMed ID: 29512102
    [No Abstract]   [Full Text] [Related]  

  • 5. Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy.
    Yahagi K; Virmani R; Kesavamoorthy B
    Cardiovasc Interv Ther; 2017 Jan; 32(1):53-55. PubMed ID: 26521263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.
    Yamaji K; Ueki Y; Souteyrand G; Daemen J; Wiebe J; Nef H; Adriaenssens T; Loh JP; Lattuca B; Wykrzykowska JJ; Gomez-Lara J; Timmers L; Motreff P; Hoppmann P; Abdel-Wahab M; Byrne RA; Meincke F; Boeder N; Honton B; O'Sullivan CJ; Ielasi A; Delarche N; Christ G; Lee JKT; Lee M; Amabile N; Karagiannis A; Windecker S; Räber L
    J Am Coll Cardiol; 2017 Nov; 70(19):2330-2344. PubMed ID: 29096803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
    Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B
    Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
    Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
    [No Abstract]   [Full Text] [Related]  

  • 9. Optical Coherence Tomography of Magnesium Bioresorbable Scaffold Restenosis.
    García-Blas S; Miñana G; Sanchis J
    Rev Esp Cardiol (Engl Ed); 2018 Dec; 71(12):1069. PubMed ID: 29223376
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioresorbable Vascular Scaffolds for Coronary Revascularization.
    Kereiakes DJ; Onuma Y; Serruys PW; Stone GW
    Circulation; 2016 Jul; 134(2):168-82. PubMed ID: 27400899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioresorbable vascular scaffolds: implication of very late scaffold thrombosis.
    Mori H; Virmani R; Finn AV
    Coron Artery Dis; 2017 Nov; 28(7):533-538. PubMed ID: 28692483
    [No Abstract]   [Full Text] [Related]  

  • 12. The pitfalls of managing thrombosis of an Absorb™-treated bifurcation.
    Schiattarella GG; Magliulo F; D'Alise G; Mannacio V; Ilardi F; Trimarco B; Esposito G; Cirillo P
    Int J Cardiol; 2014 Jul; 174(3):e93-5. PubMed ID: 24794554
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioresorbable vascular scaffold collapse causes subacute thrombosis.
    Ruiz-Salmerón RJ; Pereira S; de Araujo D
    J Invasive Cardiol; 2014 Jul; 26(7):E98-9. PubMed ID: 24993999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers?
    Leesar MA
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):870-871. PubMed ID: 27886452
    [No Abstract]   [Full Text] [Related]  

  • 15. Biodegradable drug-eluting stents: promises and pitfalls.
    Di Mario C; Ferrante G
    Lancet; 2008 Mar; 371(9616):873-4. PubMed ID: 18342665
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioresorbable Scaffolds for Coronary Stenosis: When and How Based Upon Current Studies.
    Abizaid A; Ribamar Costa J
    Curr Cardiol Rep; 2017 Mar; 19(3):27. PubMed ID: 28299676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is There Light at the End of the Thin-Strut Tunnel?: In Vitro Insights on Strut Thickness Impact on Thrombogenicity in Bioresorbable Stents or Scaffolds.
    Lu S; Ng J; Ang H; Paradies V; Wong PE; Al-Lamee R; Al-Lamee K; Bullett N; Ahmed N; Joner M; Foin N
    JACC Cardiovasc Interv; 2018 Apr; 11(7):714-716. PubMed ID: 29622153
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioresorbable Vascular Scaffold Technology Benefits From Healthy Skepticism.
    Cassese S; Kastrati A
    J Am Coll Cardiol; 2016 Mar; 67(8):932-935. PubMed ID: 26916482
    [No Abstract]   [Full Text] [Related]  

  • 19. An autopsy case of sudden cardiac death due to in-scaffold restenosis and late-scaffold thrombosis after bioresorbable vascular scaffold implantation; back to past stent era?
    Asakura K; Hao H
    Eur Heart J; 2017 Sep; 38(33):2571. PubMed ID: 28651349
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioresorbable vascular scaffold thrombosis in an all-comer patient population: single-center experience.
    Azzalini L; L'Allier PL
    J Invasive Cardiol; 2015 Feb; 27(2):85-92. PubMed ID: 25661759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.